Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jan 28:16:39-54.
doi: 10.2147/TCRM.S232033. eCollection 2020.

Uric Acid and Arterial Stiffness

Affiliations
Review

Uric Acid and Arterial Stiffness

Adriana Albu et al. Ther Clin Risk Manag. .

Abstract

Hyperuricemia is usually associated with hypertension, diabetes mellitus, metabolic syndrome and chronic kidney disease. Accumulating data from epidemiological studies indicate an association of increased uric acid (UA) with cardiovascular diseases. Possible pathogenic mechanisms include enhancement of oxidative stress and systemic inflammation caused by hyperuricemia. Arterial stiffness may be one of the possible pathways between hyperuricemia and cardiovascular disease, but a clear relationship between increased UA and vascular alterations has not been confirmed. The review summarizes the epidemiological studies investigating the relationship between UA and arterial stiffness and highlights the results of interventional studies evaluating arterial stiffness parameters in patients treated with UA-lowering drugs.

Keywords: arterial stiffness; cardiovascular risk; uric acid.

PubMed Disclaimer

Conflict of interest statement

The authors report no other conflicts of interest in this work.

Figures

Figure 1
Figure 1
Mechanisms involved in uric acid induced arterial stiffness. XO, xanthine oxidase; ROS, reactive oxygen species; URATv1, voltage- driven urate efflux transporter 1; NLRP3,nod-like receptor family protein 3; VSMCs, vascular smooth muscle cells.

Similar articles

Cited by

References

    1. Maiuolo J, Oppedisano F, Gratteri S, Muscoli C, Mollace V. Regulation of uric acid metabolism and excretion. Int J Cardiol. 2016;213:8–14. doi:10.1016/j.ijcard.2015.08.109 - DOI - PubMed
    1. Feig DI, Kang D-H, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008;359(17):1811–1821. doi:10.1056/NEJMra0800885 - DOI - PMC - PubMed
    1. Chaudhary K, Malhotra K, Sowers J, Aroor A. Uric acid key ingredient in the recipe for cardiorenal metabolic syndrome. Cardiorenal Med. 2013;3:208–220. doi:10.1159/000355405 - DOI - PMC - PubMed
    1. Wang JG, Staessen JA. Raised concentrations of serum creatinine and uric acid and the risks of mortality and cardiovascular disease. Cardiovasc Rev Rep. 2002;23:393–399.
    1. Wang JG, Staessen JA, Fagard RH, Birkenhager WH, Gong L, Liu L. Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension. Hypertension. 2001;37:1069–1074. doi:10.1161/01.hyp.37.4.1069 - DOI - PubMed